Management of iron deficiency in renal anemia: Guidelines for the optimal therapeutic approach in erythropoietin-treated patients

Clinical Nephrology

Volumn 48, Issue 1, 1997, Pages 1-8

  Drueke T B ^a   Barany P ^b   Cazzola, M ^c   Eschbach, J W ^d   Grutzmacher P ^e   Kaltwasser, J P ^f   Macdougall, I C ^g   Pippard, M J ^h   Shaldon, S ⁱ   Van Wyck, D ^j  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF PAVIA   (Italy)

^d Minor and James Medical   (United States)

^e AGAPLESION MARKUS KRANKENHAUS   (Germany)

^f UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF DUNDEE   (United Kingdom)

ⁱ NÎMES UNIVERSITY HOSPITAL   (France)

^j UNIVERSITY OF ARIZONA   (United States)

more..

Author keywords

Erythropoietin; Iron deficiency; Iron supplementation; Renal anemia

Indexed keywords

IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY; IRON THERAPY; PRACTICE GUIDELINE; REVIEW;

EID: 1842334437     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Ali M, Rigolosi R, Fayemi AO, Braun EV, Frascino J, Singer R 1982 Failure of serum ferritin levels to predict bone-marrow iron content after intravenous iron-dextran therapy. Lancet i: 652-655
2. Amitai A, Acker M 1982 Adverse effects of intramuscular iron injection. Acta Haem 68: 341-342
3. Ascherio A, Willett WC, Rimm EB, Giovannucci EL, Stampfer MJ 1994 Dietary iron intake and risk of coronary disease among men. Circulation 89: 969-974
4. Bell JD, Kincaid WR, Morgan RG, Bunce H, Alperin JB, Sarles HE, Remmers AR Jr 1980 Serum ferritin assay and bone-marrow iron stores in patients on maintenance hemodialysis. Kidney Int 17: 237-241
5. Biesma DH, Van de Wiel A, Beguin Y, Kraaijenhagen RJ, Marx JJ 1994 Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy. Eur J Clin Invest 24: 426-432
6. Birgegard G, Hallgren R, Killander A 1978 Serum ferritin during infection: a longitudinal study. Scand J Haem 21: 333-340
7. Boelaert JR, Daneels RF, Schurgers ML, Matthys EG, Gordtz BZ, Van Landuyt HW 1990 Iron overload in hemodialysis patients increases the risk of bacteremia: a prospective study. Nephrol Dial Transplant 5: 130-134
8. Brittenham GM 1994 The red cell cycle. In: Brock JH, Halliday JW, Pipard MJ, Powell LW (eds). Iron Metabolism in Health and Disease. Saunders, London, pp 31-62
9. Brugnara C, Chambers LA, Malynn E, Goldberg MA, Kruskall MS 1993 Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects. Blood 81: 956-964
10. Brugnara C, Colella GM, Cremins J, Langley RC Jr, Schneider TJ, Rutherford CJ, Goldberg MA 1994 Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis. J Lab Clin Med 123: 660-667
11. Brunner W, Hartman K, Kuhn M 1995 Parenteral iron administration: problems with iron dextran formulations. Swiss Pharmacology Journal 5: 122-123
12. Cavill I 1982 Disorders of iron metabolism. Diagnostic methods. Clin Haem 11: 259-273
13. Cazzola M, Pootrakul P, Bergamaschi G, Huebers HA, Eng M, Finch CA 1987 Adequacy of iron supply for erythropoiesis: in vivo observations in humans. J Lab Clin Med 110: 734-739
14. Cazzola M, Beguin Y 1992 New tools for clinical evaluation of erythron function in man. Br J Hematol 80: 278-284
15. Cazzola M, Ponchio L, Beguin Y, Rosti V, Bergamaschi G, Liberato NL, Fregoni V, Nalli G, Barosi G, Ascari E 1992 Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood 79: 29-37
16. Crockett RE, Baillod RA, Lee BN, Moorhead JF, Stevenson CM, Varghese Z, Shaldon S 1967 Maintenance of fifty patients on intermittent hemodialysis without blood transfusion. Proc Eur Dial Transpl Ass iv: 17-22
17. Donnelly SM, Posen GA, Ali MA 1991 Oral iron absorption in hemodialysis patients treated with erythropoietin. Clin Invest Med 14: 271-276
18. Drücke T 1995 r-Hu EPO hyporesponsiveness - who and why? Nephrol Dial Transplant 10 (Suppl 2): 62-68
19. Eschbach JW, Cook JD, Scribner BH, Finch CA 1977 Iron balance in hemodialysis patients. Ann Intern Med 87: 710-713
20. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW 1987 Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 316: 73-78
21. Eschbach JW, Holey NR, Egrie JC, Adamson JW 1992 A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects. Kidney Int 42: 407-416
22. Eschbach JW 1996 Hematological problems of renal failure. In: Drukker. Parsons and Maher. Replacement of Renal Function by Dialysis, 4th ed. Jacobs C, Kjellstrand CM, Koch KM, Winchester FJ (eds). Nijhoff BV
23. Ferguson BJ, Skikne BS, Simpson KM, Baynes RD, Cook JD 1992 Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J Lab Clin Med 119: 385-390
24. Flowers CH, Skikne BS, Covell AM, Cook JD 1989 The clinical measurement of serum transferrin receptor. J Lab Clin Med 114: 368-377
25. Gokal R, Millard PR, Weatherall DJ, Callender ST, Ledingham JG, Oliver DO 1979 Iron metabolism in hemodialysis patients. A study of the management of iron therapy and overload. Q J Med 48: 369-391
26. Granolleras C, Oules R, Branger B, Fourcade J, Shaldon S 1993 Iron supplementation of hemodialysis patients receiving recombinant human erythropoietin therapy. In: Bauer C, Koch KM, Scigalla P, Wieczorek L (eds). Erythropoietin: Molecular Physiology and Clinical Applications. Marcel Dekker, New York, pp 211-218
27. Green R, Charlton R, Seftel H, Bothwell T, Mayet F, Adams B, Finch C, Layrisse M 1968 Body iron excretion in man: a collaborative study. Am J Med 45: 336-353
28. Hamstra RD, Block MH, Schocket AL 1980 Intravenous iron dextran in clinical medicine. JAMA 243: 1726-1731
29. Hedin H, Richter W, Ring J 1976 Dextran-induced anaphylactoid reactions in man: role of dextran reactive antibodies. Int Arch Allergy Immunol 52: 145-159
30. Huebers HA, Finch CA 1987 The physiology of transferrin and transferrin receptors. Physiol Rev 67: 520-582
31. Huebers HA, Beguin Y, Pootrakul P, Einspahr D, Finch CA 1990 Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood 75: 102-107
32. Huebers HA, Csiba E, Huebers E, Finch CA 1982 Competitive advantage of diferric transferrin in delivering iron to reticulocytes. Proc Natl Acad Sci USA 80: 300-304
33. Hushes RT, Smith T, Hesp R et al 1992 Regulation of iron absorption in iron loaded subjects with end stage renal disease: effects of treatment with recombinant human erythropoietin and reduction of iron stores. Br J Haematol 82: 445-454
34. Jacobs A, Worwood M 1975 Ferritin in serum. Clinical and biochemical implications, N Engl J Med 292: 951-956
35. Kohgo Y, Nishisato T, Kondo H, Tsushima N, Niitsu Y, Urushizaki I 1986 Circulating transferrin receptor in human serum. Br J Haematol 64: 277-281
36. Kohgo Y, Niitsu Y, Nishisato T, Kato J, Kondo H, Sasaki K, Urushizaki I 1988 Quantitation and characterization of serum transferrin receptor in patients with anemias and polycythemias. Jpn J Med 27: 64-70
37. Konijn AM. Hershko C 1977 Ferritin synthesis in inflammation: pathogenesis of impaired iron release. Br J Haematol 37: 7-16
38. Kooistra MP, Van Es A, Struyvenberg A, Marx JJM 1995 Low iron absorption in erythropoietin-treated hemodialysis patients. J Am Soc Nephrol 6: 543
39. Kothari T, Swamy AP, Lee JC, Mangla JC, Cestero RV 1980 Hepatic hemosiderosis in maintenance hemodialysis (MHD) patients. Dig Dis Sci 25: 363-368
40. Lauffer KB 1991 Iron stores and the international variation in mortality from coronary artery disease. Med Hypotheses 55: 96-102
41. Lee GR 1983 The anemia of chronic disease. Semin Hematol 20: 61-80
42. Lee GR 1993 Microcytosis and anemias associated with impaired hemoglobin synthesis. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN (eds). Wintrobe's Clinical Hematology. Lea & Febiger, Philadelphia, pp 800-801
43. Lowrie EG, Huang WH, Lew NL 1995 Death risk predictors among peritoneal dialysis and hemodialysis patients: a preliminary comparison. Am J Kidney Dis 26: 220-228
44. Macdougall IC 1994 Monitoring of iron status and iron supplementation in patients treated with erythropoietin. Curr Opin Nephrol Hypertens 3: 620-625
45. Macdougall IC, Cavill I, Hulme B, Bain B, McGregor E, McKay P, Sanders E, Coles GA, Williams JD 1992 Detection of functional iron deficiency during erythropoietin treatment: a new approach. BMJ 304: 225-226
46. Magnusson MK, Sigfusson N, Sigvaldason H, Johannesson GM, Magnusson S, Thorgeirsson G 1994 Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 89: 102-108
47. Means RT Jr. Krantz SB 1992 Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80: 1639-1647
48. Milman N, Christensen TE, Pedersen NS, Visfeldt J 1980 Serum ferritin and bone marrow iron in non-dialysis, peritoneal dialysis and hemodialysis patients with chronic renal failure. Acta Med Scand 207: 201-205
49. Mirhanadi KS, Wellington MR Winer RL, Dahir-Vaziri N, Byer B, Gorman JT, Rosen SM 1977 Serum ferritin level. Determinant of iron requirement in hemodialysis patients. JAMA 238: 601-608
50. Müller-Wiefel DE, Scigalla P 1988 Specific problems of renal anemia in childhood, Contrib Nephrol 66: 71-84
51. Pincus T, Olsen NJ, Russell U, Wolfe F, Harris ER, Schnitzer TJ, Boccagno JA, Krantz SB 1990 Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 89: 161-168
52. Ratcliffe PF 1994 Nephrology forum: molecular biology of erythropoietin. Kidney Int 44: 887
53. Remuzzi G 1988 Bleeding in renal failure. Lancet i: 1205-1208
54. Salonen JT, Nyyssonen K, Korpels H, Tuomilehto J, Seppanen R, Salonen R 1992 High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation 86: 803-811
55. Schaefer RM, Schaefer L 1992 Management of iron substitution during rh-EPO therapy in chronic renal failure patients. Erythropoiesis 3: 71-75
56. Sears DA 1992 Anemia of chronic disease. Med Clin North Am 76: 567-579
57. Seligman PA 1983 Structure and function of the transferrin receptor. Prog Hematol 13: 131-147
58. Skikne BS, Cook JD 1992 Effect of enhanced erythropoiesis on iron absorption. J Lab Clin Med 120: 746-751
59. Skikne BS, Flowers CH, Cook JD 1990 Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood 75: 1870-1876
60. Sullivan JL 1981 Iron and the sex difference in heart disease risk. Lancet i: 1293-1294
61. Sunder-Plassmann G, Hörl WH 1995 Importance of iron supply for erythropoietin therapy. Nephrol Dial Transplant 10: 2070-2076
62. Takashina N, Kondo H, Kashiwazaki S 1990 Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis. J Rheumatol 17: 885-887
63. Taylor JE, Peat N, Morgan AG 1996 Regular low-dose intravenous iron therapy improves response to erythropoietin in hemodialysis patients. Nephrol Dial Transplant 11: 1079-1083
64. Trowhridge IS, Newman RA, Domingo DL, Sauvage C 1984 Transferrin receptors: structure and function. Biochem Pharmacol 33: 925-932
65. Tsobanelis T, Hoppe D, Scigalla P, Grützmacher P 1991 Optimierte Behandlung der renalen Anämie mit kombinierter intravenöser Eisen- und Ultra-low-dose-Erythropoietin-Substitution. Nieren-Hochdruckkrankheiten 20: 454
66. van Wyck DB, Stivelman JC, Ruiz J, Kirlin LF, Katz MA, Ogden DA 1989 Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney Int 35: 712-716
67. Vreugdenhil G, Wognum AW, van Eijk HG, Swaak AJ 1990 Anemia in rheumatoid arthritis: the role of iron, vitamin B12 and folic acid deficiency, and erythropoietin responsiveness. Ann Rheum Dis 49: 93-98
68. Ward JH 1987 The structure, function and regulation of transferrin receptors. Invest Radiol 22: 74-83
69. Worwood M 1994 Laboratory determination of iron status. In: Brock JH, Halliday JW, Pippard MJ, Powell LW (eds). Iron Metabolism in Health and Disease. W. B. Saunders, London, pp 449-476